Activation of HIF-1α, reduction of GPC3 expression, inhibition of HCC cell proliferation, migration and epithelial-mesenchymal transition, inhibition of Wnt/β-catenin signaling pathway, inhibition of tumor growth and angiogenesis. This evidence concerns the gene HIF1A and hepatocellular carcinoma.